According to J.P. Morgan, UnitedHealth Group UNH reported 2Q EPS at $1.16, about $0.27 ahead of estimate, while ex a potential $0.15 charge we had incorporated, the report would have come in $0.12 ahead.
J.P. Morgan said that, much like prior quarters, the upside was mostly on lower medical costs, with utilization remaining constrained, this a factor that should not be much of a surprise by now. “We are raising our 2011E EPS by $0.20 to $4.25 and our 2012E by $0.15 to $4.65. Our year-end '12 price target is $60/share.”
UnitedHealth Group closed yesterday at $51.45.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in